Copyright Reports & Markets. All rights reserved.

Global Metabolomics Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Metabolomics Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Introduction
      • 1.4.3 Separation Techniques
      • 1.4.4 Detection Techniques
    • 1.5 Market by Application
      • 1.5.1 Global Metabolomics Market Share by Application (2014-2025)
      • 1.5.2 Introduction
      • 1.5.3 Drug Assessment
      • 1.5.4 Biomarker Discovery
      • 1.5.5 Nutrigenomics
      • 1.5.6 Clinical toxicology
      • 1.5.7 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Metabolomics Market Size
    • 2.2 Metabolomics Growth Trends by Regions
      • 2.2.1 Metabolomics Market Size by Regions (2014-2025)
      • 2.2.2 Metabolomics Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Metabolomics Market Size by Manufacturers
      • 3.1.1 Global Metabolomics Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Metabolomics Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Metabolomics Market Concentration Ratio (CR5 and HHI)
    • 3.2 Metabolomics Key Players Head office and Area Served
    • 3.3 Key Players Metabolomics Product/Solution/Service
    • 3.4 Date of Enter into Metabolomics Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Metabolomics Market Size by Type (2014-2019)
    • 4.2 Global Metabolomics Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Metabolomics Market Size (2014-2019)
    • 5.2 Metabolomics Key Players in United States
    • 5.3 United States Metabolomics Market Size by Type
    • 5.4 United States Metabolomics Market Size by Application

    6 Europe

    • 6.1 Europe Metabolomics Market Size (2014-2019)
    • 6.2 Metabolomics Key Players in Europe
    • 6.3 Europe Metabolomics Market Size by Type
    • 6.4 Europe Metabolomics Market Size by Application

    7 China

    • 7.1 China Metabolomics Market Size (2014-2019)
    • 7.2 Metabolomics Key Players in China
    • 7.3 China Metabolomics Market Size by Type
    • 7.4 China Metabolomics Market Size by Application

    8 Japan

    • 8.1 Japan Metabolomics Market Size (2014-2019)
    • 8.2 Metabolomics Key Players in Japan
    • 8.3 Japan Metabolomics Market Size by Type
    • 8.4 Japan Metabolomics Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Metabolomics Market Size (2014-2019)
    • 9.2 Metabolomics Key Players in Southeast Asia
    • 9.3 Southeast Asia Metabolomics Market Size by Type
    • 9.4 Southeast Asia Metabolomics Market Size by Application

    10 India

    • 10.1 India Metabolomics Market Size (2014-2019)
    • 10.2 Metabolomics Key Players in India
    • 10.3 India Metabolomics Market Size by Type
    • 10.4 India Metabolomics Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Metabolomics Market Size (2014-2019)
    • 11.2 Metabolomics Key Players in Central & South America
    • 11.3 Central & South America Metabolomics Market Size by Type
    • 11.4 Central & South America Metabolomics Market Size by Application

    12 International Players Profiles

    • 12.1 Thermo Fisher Scientific, Inc.
      • 12.1.1 Thermo Fisher Scientific, Inc. Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Metabolomics Introduction
      • 12.1.4 Thermo Fisher Scientific, Inc. Revenue in Metabolomics Business (2014-2019)
      • 12.1.5 Thermo Fisher Scientific, Inc. Recent Development
    • 12.2 Agilent Technologies, Inc.
      • 12.2.1 Agilent Technologies, Inc. Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Metabolomics Introduction
      • 12.2.4 Agilent Technologies, Inc. Revenue in Metabolomics Business (2014-2019)
      • 12.2.5 Agilent Technologies, Inc. Recent Development
    • 12.3 Biocrates Life Sciences AG
      • 12.3.1 Biocrates Life Sciences AG Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Metabolomics Introduction
      • 12.3.4 Biocrates Life Sciences AG Revenue in Metabolomics Business (2014-2019)
      • 12.3.5 Biocrates Life Sciences AG Recent Development
    • 12.4 Shimadzu Corporation
      • 12.4.1 Shimadzu Corporation Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Metabolomics Introduction
      • 12.4.4 Shimadzu Corporation Revenue in Metabolomics Business (2014-2019)
      • 12.4.5 Shimadzu Corporation Recent Development
    • 12.5 Waters Corporation
      • 12.5.1 Waters Corporation Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Metabolomics Introduction
      • 12.5.4 Waters Corporation Revenue in Metabolomics Business (2014-2019)
      • 12.5.5 Waters Corporation Recent Development
    • 12.6 Human Metabolome Technologies, Inc.
      • 12.6.1 Human Metabolome Technologies, Inc. Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Metabolomics Introduction
      • 12.6.4 Human Metabolome Technologies, Inc. Revenue in Metabolomics Business (2014-2019)
      • 12.6.5 Human Metabolome Technologies, Inc. Recent Development
    • 12.7 LECO Corporation
      • 12.7.1 LECO Corporation Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Metabolomics Introduction
      • 12.7.4 LECO Corporation Revenue in Metabolomics Business (2014-2019)
      • 12.7.5 LECO Corporation Recent Development
    • 12.8 Metabolon, Inc.
      • 12.8.1 Metabolon, Inc. Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Metabolomics Introduction
      • 12.8.4 Metabolon, Inc. Revenue in Metabolomics Business (2014-2019)
      • 12.8.5 Metabolon, Inc. Recent Development
    • 12.9 Bio-Rad Laboratories, Inc.
      • 12.9.1 Bio-Rad Laboratories, Inc. Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Metabolomics Introduction
      • 12.9.4 Bio-Rad Laboratories, Inc. Revenue in Metabolomics Business (2014-2019)
      • 12.9.5 Bio-Rad Laboratories, Inc. Recent Development
    • 12.10 Bruker Corporation
      • 12.10.1 Bruker Corporation Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Metabolomics Introduction
      • 12.10.4 Bruker Corporation Revenue in Metabolomics Business (2014-2019)
      • 12.10.5 Bruker Corporation Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      In 2018, the global Metabolomics market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.

      This report focuses on the global Metabolomics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Metabolomics development in United States, Europe and China.

      The key players covered in this study
      Thermo Fisher Scientific, Inc.
      Agilent Technologies, Inc.
      Biocrates Life Sciences AG
      Shimadzu Corporation
      Waters Corporation
      Human Metabolome Technologies, Inc.
      LECO Corporation
      Metabolon, Inc.
      Bio-Rad Laboratories, Inc.
      Bruker Corporation

      Market segment by Type, the product can be split into
      Introduction
      Separation Techniques
      Detection Techniques

      Market segment by Application, split into
      Introduction
      Drug Assessment
      Biomarker Discovery
      Nutrigenomics
      Clinical toxicology
      Others

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Metabolomics status, future forecast, growth opportunity, key market and key players.
      To present the Metabolomics development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Metabolomics are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now